Share this article and save a life!
CMS just made your routine chest CT a cardiac screening tool.
And most imaging centers do not realize what that means for their revenue, or their patients.
Starting April 1, 2026, health systems and imaging centers can bill Medicare for AI-powered detection of coronary artery calcium and aortic valve calcium found incidentally on chest CTs. Bunkerhill Health was first to secure this reimbursement pathway, and the implications are enormous.
Here is the part that matters most.
More than 20 million chest CTs are performed in the U.S. every year. The vast majority are ordered for pulmonary or oncological reasons, not cardiac ones. But heart disease is hiding in those scans. AI can now find it automatically, flag the risk, and your team can bill for it.
That is not a minor billing update. That is a structural shift in how preventive cardiology gets delivered.
🫀 What makes this different from prior cardiac screening efforts:
Traditional coronary calcium scoring requires a dedicated low-dose CT scan ordered specifically for cardiac risk. Patients have to show up for it. Doctors have to think to order it. Underserved populations rarely get it.
Opportunistic screening flips the model entirely. The patient is already in the scanner. The AI runs in the background. The finding surfaces automatically. No extra visit, no extra order, no extra cost to the patient.
For FQHCs and community health centers, this matters even more. Your patients are less likely to get elective cardiac screening. They are more likely to have undiagnosed cardiovascular disease. If you have a CT program or a radiology partnership, opportunistic AI screening is one of the most equitable preventive tools now available to you.
📋 What imaging centers and health systems should be asking right now:
Is your AI vendor cleared for coronary and aortic valve calcium detection? Not all chest CT AI tools cover this. Clearance and billing eligibility are two different hurdles.
Is your radiology workflow set up to surface and act on incidental cardiac findings? Detection without a follow-up pathway is a liability, not a feature.
Are your billing and compliance teams aware of the new code structure? This is still new territory and documentation requirements matter.
Do your referring providers know this capability exists? Most primary care physicians do not yet know their patients could get a cardiac risk flag from a chest CT they already ordered.
The economics here are straightforward. A chest CT that already covers its cost now generates an additional billable finding, without additional radiation, without rescheduling, and without added patient burden.
The clinical case is even stronger. Coronary artery calcium is one of the most validated predictors of cardiovascular events. Getting that data in front of a provider while a patient is already engaged in care is exactly what preventive medicine is supposed to look like.
The bigger question for health system leaders is this: how many of your patients already had calcium hiding in their scans over the last five years, and no one ever flagged it because the billing pathway did not exist?
That window is now open. The question is whether your organization is ready to walk through it.
♻️ Repost if every chest CT should be working harder for your patients.
👉 Follow me for daily healthcare updates and get the deeper analysis in my Substack newsletter → https://lnkd.in/eJKFuB_p
Share this article and save a life!
Author:

CEO/Co-Founder @ Oatmeal Health | AI Lung Cancer Screening | Almost Became a Doctor | Engineer | Follow to Share What I’ve Learned Along the Way
I help patients get the care they need earlier, preventing late-stage cancer.
That’s been the throughline across three companies and almost 20 years in healthcare. At ReferralMD, we fixed broken referral networks so patients didn’t fall through the cracks. At Oatmeal Health, it’s lung cancer: building the diagnostic and screening infrastructure so the 85% of cases caught too late get caught early instead.
Today as CEO of Oatmeal Health, I lead a team embedding AI into radiology workflows to turn routine lung CT scans into reimbursable cancer risk assessments. We partner with FQHCs to reach underserved communities, and with health systems and payers to make early detection economically sustainable. Think HeartFlow or Cleerly, but for lungs.
Between companies, I advised at Techstars and Plug and Play, mentoring founders building in digital health. That experience shaped how I think about what separates companies that ship from companies that stall: distribution, reimbursement, and clinical trust, not just technology.
I’m a CancerX alumnus, a 3x healthcare founder, and someone who believes the biggest problems in cancer aren’t scientific. They’re operational.
We’re hiring mission-driven builders at Oatmeal Health. If you want to work on something that matters, reach out.
When I’m not working, I’m traveling, mentoring, and keeping up with one very energetic husky. 🐾
Substack – The Oatmeal Bite:
Millions of patients get less care because of who they are, where they live, or how they look. I’m fighting to change that. CEO @OatmealHealth, a startup built for the underserved. The Oatmeal Bite: intel for clinicians, investors, and advocates.
Jonathan Govette
CEO of Oatmeal Health
Substack:
https://oatmealhealthjonathangovette.substack.com/




